Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium hyaluronate injection for transient improvement of facial skin condition
ChiCTR2600119641Phase 3Completed
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sodium hyaluronate (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoints: Improvement rate on the Comprehensive Scale for Transient Alleviation of Skin Dryness and Dullness and Improvement rate of Allergan Skin Roughness Scale (ASRS). Started Mar 2026; status: completed.
02
Drugs
sodium hyaluronate
Beyond the preview
Go deeper on ChiCTR2600119641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119641.